Kyntra Bio, Inc. · NASDAQ:KYNB
Wettig Thane bought 2,800 Kyntra Bio, Inc. shares (Form 4/A)
Traded May 14, 2026 · Filed May 19, 2026
On May 14, 2026, Wettig Thane (Director, CEO) bought 2,800 Kyntra Bio, Inc. shares at US$7.09 for US$19,852, leaving 27,203 shares. Filed May 19, 2026 (Form 4/A).
- Bought
- 2,800 shares
- Price
- US$7.09
- Value
- US$19,852
- Holding after
- 27,203 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Buy | 2,800 | US$7.09 | 27,203 | Direct |
Source
Related
- Kyntra Bio, Inc.
- Wettig Thane
- Kyntra Bio, Inc. shareholders
- Form 4 · Wettig Thane · Sep 9, 2026
- Form 4 · Wettig Thane · Jun 9, 2026
- Form 4 · DeLucia David · Sep 9, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · DeLucia David · Jun 9, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026